カテゴリー： MarketsandMarkets, 世界, 医療/バイオ

世界の遺伝子発現解析市場（～2029年）：製品別（試薬、酵素、キット、DNAチップ、PCR、NGS、DNAマイクロアレイ）、サービス別（RNAシーケンス、バイオインフォマティクス）、用途別（創薬・開発、臨床診断）、エンドユーザー別

◆英語タイトル：Gene Expression Analysis Market by Product (Reagents, Enzymes, kits, DNA Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Bioinformatics), Application (Drug discovery & development, clinical diagnostics), End User - Global Forecast to 2029
	◆商品コード：BT2236-24 ◆発行会社（リサーチ会社）：MarketsandMarkets ◆発行日：2024年3月 ◆ページ数：370 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後24時間以内） ◆調査対象地域：グローバル ◆産業分野：バイオ

◆販売価格オプション（消費税別）

Single User（1名様閲覧）	USD4,950 ⇒換算￥732,600	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥984,200	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥1,206,200	見積依頼/購入/質問フォーム

★MarketsandMarketsに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

“遺伝子発現解析市場は、2024年の推定42億米ドルから2029年62億米ドルまで、年平均成長率8.1%で成長すると予測”この市場の成長は、ゲノミクス研究への投資が増加していることに起因していると考えられ、遺伝学的研究のための政府資金が利用可能であることも、市場の拡大にさらに貢献しています。遺伝子発現解析分野は、遺伝子制御と分子メカニズムの理解を深めながら進化を続けており、遺伝子発現解析市場は継続的な成長と革新が見込まれています。

“2023年の機器別シェアはPCR機器セグメントが最大に”
2023年、世界の遺伝子発現解析市場において、PCR装置セグメントは、製品&サービスの装置サブセグメントで最大のシェアを占めました。PCR装置は、製薬、バイオテクノロジー、学術研究、臨床診断、法医学など、さまざまな産業で広く採用されています。この幅広い応用範囲がPCR装置の大きな市場シェアに貢献しています。

“アジア太平洋地域は、2024-2029年の予測期間中、市場で最も高いCAGRで成長”
アジア太平洋地域は、予測期間中に最も高い成長率で成長すると予想されています。この地域は、プロテオミクスおよびゲノミクス研究の拡大、研究資金の増加、製薬企業およびバイオテクノロジー企業からの投資の拡大、個別化治療薬を取り巻く意識の高まりに後押しされ、急成長を遂げると予測されています。インドと中国はアジア太平洋地域で最も高い成長を示すと予想され、特に診断の利点に関連する手頃な価格と意識の高まりがその理由です。

本レポートのために実施した一次インタビューは以下のように分類されます：
- 回答者別供給側70％、需要側30%
- 役職別管理職：45%、CXOおよび取締役：30%、経営幹部：25%
- 地域別北米：45％、欧州：20％、アジア太平洋地域：20％、中南米：10％、中東・アフリカ：5%

レポート掲載企業一覧
• Thermo Fisher Scientific Inc (US)
• Bio-Rad Laboratories Inc. (US)
• Illumina Inc (US)
• QIAGEN (Netherlands)
• F. Hoffmann-La Roche (Switzerland)
• Revvity (US)
• PacBio (US)
• Agilent Technologies Inc (US)
• Oxford Gene Technology IP Limited (UK)
• BGI (China)
• Eurofins Scientific (Luxembourg)
• Standard BioTools (US)
• Oxford Nanopore Technologies plc (UK)
• GenScript (US)
• タカラバイオ（日本）
• 10x Genomics (US)
• Zymo Research Corporation (US)
• Twist Bioscience (US)
• Promega Corporation (US)
• LGC Limited (UK)
• CD Genomics (US)
• NanoString Technologies Inc. (US)
• BioSpyder, Inc (US)
• Integrated DNA Technologies, Inc (US)
• New England Biolabs (US)

調査範囲
本調査レポートでは、遺伝子発現解析市場を製品・サービス（装置、試薬・消耗品、サービス（遺伝子発現解析サービス、バイオインフォマティクスサービス））、用途（臨床診断、創薬・医薬品開発、その他（発生生物学、薬理ゲノミクス、環境応答、法医学研究、農業研究））、エンドユーザー（製薬・バイオテクノロジー企業、学術・研究機関、その他（臨床研究所、CRO、法医学研究所、農業・環境団体））、地域別（北米、欧州、アジア太平洋、中南米、中東、アフリカ）に区分しています。本レポートでは、遺伝子発現解析市場の成長に影響を与える促進要因、課題、機会、動向などの主要要因に関する詳細情報を網羅しています。本レポートでは、主要な産業プレイヤーを詳細に分析し、そのビジネスプロフィール、製品/サービスの提供、および遺伝子発現解析市場における提携、パートナーシップ、事業拡大、合意、買収、最近の開発などの戦略的イニシアティブに関する洞察を提供します。さらに、遺伝子発現解析市場のエコシステムにおける主要企業や新興新興企業の競合分析も網羅しています。

レポート購入の主な利点
本レポートは、遺伝子発現解析市場全体とそのサブセグメントにおける収益数の最も近い概算値を提供することで、市場リーダーや新規参入者を支援します。また、利害関係者が競合状況をより良く理解し、より多くの洞察を得ることで、自社のビジネスをより良く位置づけ、適切な市場参入戦略を立てるのに役立ちます。本レポートは、利害関係者が市場の脈動を理解し、主要な市場促進要因、阻害要因、機会、および課題に関する情報を提供することを可能にします。

本レポートは、以下のポイントに関する洞察を提供します：
- 市場の成長に影響を与える主要な促進要因（遺伝子編集技術の進歩、ゲノム研究に対する資金提供の増加、治療への応用に対する嗜好の高まり、シーケンスコストの低下）、阻害要因（機器および消耗品の高コスト、データのプライバシーとセキュリティに関連する懸念）、機会（非医療分野での応用拡大、機械学習とAI、シングルセル解析への注目の高まり）、課題（承認までのタイムラインの長期化、データ解釈の課題）の分析。
- 製品開発/イノベーション：遺伝子発現解析市場の新製品に関する詳細なインサイト
- 市場開発：有利な市場に関する包括的な情報 - 本レポートでは様々な地域の市場を分析しています。
- 市場の多様化：遺伝子発現解析市場における新製品/サービス、未開拓地域、最近の開発、投資に関する詳細情報
- 競合他社の評価：Thermo Fisher Scientific Inc（米国）、Bio-Rad Laboratories Inc.（米国）、Illumina Inc（米国）、QIAGEN（オランダ）、F. Hoffmann-La Roche（スイス）、Revvity（米国）、PacBio（米国）、Agilent Technologies Inc（米国）、Oxford Gene Technology IP Limited（英国）、BGI（中国）、Eurofins Scientific（ルクセンブルク）、Standard BioTools（米国）、Oxford Nanopore Technologies plc（英国）、 GenScript（米国）、タカラバイオ（日本）、10x Genomics（米国）、Zymo Research Corporation（米国）、Twist Bioscience（米国）、Promega Corporation（米国）、LGC Limited（英国）、CD Genomics（米国）、NanoString Technologies Inc. （米国）、BioSpyder, Inc（米国）、Integrated DNA Technologies, Inc（米国）、New England Biolabs（米国）など。

1 はじめに
2 調査方法
3 エグゼクティブサマリー
4 プレミアムインサイト
5 市場概要
6 遺伝子発現解析市場：製品・サービス別
7 遺伝子発現解析市場：用途別
8 遺伝子発現解析市場：エンドユーザー別
9 遺伝子発現解析市場：地域別
10 競争状況
11 企業プロファイル
12 付録

❖ レポートの目次 ❖

1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 31
1.2.1 INCLUSIONS & EXCLUSIONS 31
1.3 MARKET SCOPE 32
1.3.1 MARKETS COVERED 32
1.3.2 REGIONS COVERED 33
1.3.3 YEARS CONSIDERED 33
1.3.4 CURRENCY CONSIDERED 34
1.4 RESEARCH LIMITATIONS 34
1.5 STAKEHOLDERS 34
1.6 SUMMARY OF CHANGES 35
1.7 RECESSION IMPACT 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
FIGURE 1 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 37
2.1.2 PRIMARY DATA 38
FIGURE 2 GENE EXPRESSION ANALYSIS MARKET: BREAKDOWN OF PRIMARIES 38
2.2 MARKET SIZE ESTIMATION 39
FIGURE 3 MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023 39
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2023 40
FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2023 40
2.2.1 INSIGHTS FROM PRIMARIES 42
FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS 42
2.2.2 SEGMENT ASSESSMENT (BY PRODUCT & SERVICE, APPLICATION, AND END USER) 42
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 42
2.3 GROWTH RATE ASSUMPTIONS 43
FIGURE 8 GENE EXPRESSION ANALYSIS MARKET: CAGR PROJECTIONS (2024–2029) 44
FIGURE 9 GENE EXPRESSION ANALYSIS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES 44
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 45
FIGURE 10 DATA TRIANGULATION METHODOLOGY 45
2.5 STUDY ASSUMPTIONS 46
2.6 RISK ANALYSIS 46
2.7 RECESSION IMPACT ANALYSIS 46
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2024–2028 (% GROWTH) 47
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 47
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 47
3 EXECUTIVE SUMMARY 48
FIGURE 11 GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD MILLION) 48
FIGURE 12 GENE EXPRESSION SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 49
FIGURE 13 GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 49
FIGURE 14 GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 50
FIGURE 15 GEOGRAPHIC SNAPSHOT OF GENE EXPRESSION ANALYSIS MARKET 51
4 PREMIUM INSIGHTS 52
4.1 GENE EXPRESSION ANALYSIS MARKET OVERVIEW 52
FIGURE 16 ADVANCEMENTS IN GENE EDITING TECHNOLOGIES TO DRIVE MARKET 52
4.2 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2023 53
FIGURE 17 PRODUCT & SERVICE SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 53
4.3 GENE EXPRESSION ANALYSIS MARKET SHARE, BY PRODUCT & SERVICE, 2024 VS. 2029 53
FIGURE 18 PRODUCT & SERVICE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 53
4.4 GENE EXPRESSION ANALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 54
FIGURE 19 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
FIGURE 20 GENE EXPRESSION ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
5.2.1 DRIVERS 56
5.2.1.1 Advancements in gene editing technologies 56
5.2.1.2 Increasing funding initiatives for genomic research 57
5.2.1.3 Growing preference for therapeutic applications 57
5.2.1.4 Declining costs of sequencing technologies 58
FIGURE 21 COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001–2022 59
5.2.2 RESTRAINTS 59
5.2.2.1 High cost of instruments & consumables 59
5.2.2.2 Concerns associated with data privacy and security 60
5.2.3 OPPORTUNITIES 61
5.2.3.1 High growth potential across non-clinical applications 61
5.2.3.2 Machine learning and AI 62
5.2.3.3 Growing focus on single-cell analysis 63
5.2.4 CHALLENGES 64
5.2.4.1 Extensive timelines for product approval 64
5.2.4.2 Data interpretation challenges 64
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 65
FIGURE 22 REVENUE SHIFT TOWARDS GENE EXPRESSION ANALYSIS COMPANIES 65
5.4 PRICING ANALYSIS 66
5.4.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT 66
TABLE 4 GENE EXPRESSION ANALYSIS PRODUCT PRICE 66
5.5 VALUE CHAIN ANALYSIS 67
FIGURE 23 GENE EXPRESSION ANALYSIS MARKET: VALUE CHAIN ANALYSIS 68
5.6 SUPPLY CHAIN ANALYSIS 69
FIGURE 24 GENE EXPRESSION ANALYSIS MARKET: SUPPLY CHAIN ANALYSIS 69
TABLE 5 GENE EXPRESSION ANALYSIS MARKET: SUPPLY CHAIN ANALYSIS 70
5.7 ECOSYSTEM ANALYSIS 71
FIGURE 25 GENE EXPRESSION ANALYSIS MARKET ECOSYSTEM 71
5.7.1 GENE EXPRESSION ANALYSIS MARKET: REAGENT & CONSUMABLE VENDORS 72
TABLE 6 GENE EXPRESSION ANALYSIS MARKET: REAGENT & CONSUMABLE VENDORS 72
5.7.2 GENE EXPRESSION ANALYSIS MARKET: INSTRUMENT VENDORS 72
TABLE 7 GENE EXPRESSION ANALYSIS MARKET: INSTRUMENT VENDORS 72
5.7.3 GENE EXPRESSION ANALYSIS MARKET: END USERS 73
TABLE 8 GENE EXPRESSION ANALYSIS MARKET: END USERS 73
5.7.4 GENE EXPRESSION ANALYSIS MARKET: REGULATORY BODIES 73
TABLE 9 GENE EXPRESSION ANALYSIS MARKET: REGULATORY BODIES 73
5.8 TECHNOLOGY ANALYSIS 74
5.9 PATENT ANALYSIS 75
5.9.1 PATENTS FILED, BY DOCUMENT TYPE, 2014–2024 75
TABLE 10 PATENTS FILED, 2014–2024 75
5.9.2 INNOVATION & PATENT APPLICATIONS 75
FIGURE 26 TOTAL NUMBER OF PATENTS GRANTED, 2014–2023 75
5.9.3 TOP APPLICANTS 76
FIGURE 27 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014–2024 76
FIGURE 28 REGIONAL ANALYSIS OF PATENTS GRANTED, 2014–2024 76
TABLE 11 TOP 12 PATENT OWNERS IN GENE EXPRESSION ANALYSIS MARKET, 2014–2024 77
TABLE 12 PATENTS IN GENE EXPRESSION ANALYSIS MARKET (2024) 77
5.10 TRADE DATA 79
5.10.1 INSTRUMENTS & APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS 79
TABLE 13 IMPORT VOLUME FOR INSTRUMENTS & APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS (HS CODE-902780), 2018–2022 (TONS) 80
TABLE 14 EXPORT VOLUME FOR INSTRUMENTS & APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS (HS CODE-902780), 2018–2022 (TONS) 80
5.10.2 MICROTOMES: PARTS & ACCESSORIES OF INSTRUMENTS AND APPARATUS FOR PHYSICAL/CHEMICAL ANALYSIS 81
TABLE 15 IMPORT VOLUME FOR MICROTOMES: PARTS & ACCESSORIES OF INSTRUMENTS AND APPARATUS FOR PHYSICAL/CHEMICAL ANALYSIS (HS CODE-902790), 2018–2022 (TONS) 81
TABLE 16 EXPORT VOLUME FOR MICROTOMES: PARTS & ACCESSORIES OF INSTRUMENTS AND APPARATUS FOR PHYSICAL/CHEMICAL ANALYSIS (HS CODE-902790), 2018–2022 (TONS) 81
5.11 KEY CONFERENCES & EVENTS 82
5.11.1 GENE EXPRESSION ANALYSIS MARKET: CONFERENCES & EVENTS IN 2024–2025 82
TABLE 17 GENE EXPRESSION ANALYSIS MARKET: CONFERENCES & EVENTS (2024–2025) 82
5.12 REGULATORY LANDSCAPE 83
5.12.1 CBER REGULATIONS ON GENE EXPRESSION ANALYSIS 83
5.12.2 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 18 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 19 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
TABLE 20 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86
TABLE 21 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87
5.13 PORTER’S FIVE FORCES ANALYSIS 88
TABLE 22 GENE EXPRESSION ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS 88
5.13.1 THREAT OF NEW ENTRANTS 88
5.13.2 THREAT OF SUBSTITUTES 89
5.13.3 BARGAINING POWER OF BUYERS 89
5.13.4 BARGAINING POWER OF SUPPLIERS 89
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 89
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 90
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 90
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR GENE EXPRESSION ANALYSIS PRODUCTS & SERVICES 90
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR END USERS 90
5.14.2 BUYING CRITERIA FOR GENE EXPRESSION ANALYSIS PRODUCTS 91
FIGURE 30 KEY BUYING CRITERIA FOR END USERS 91
TABLE 24 KEY BUYING CRITERIA FOR TOP FOUR END USERS 91

6 GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE 93
6.1 INTRODUCTION 94
TABLE 25 GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 94
6.2 REAGENTS & CONSUMABLES 94
TABLE 26 GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 95
TABLE 27 GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION) 95
TABLE 28 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 96
TABLE 29 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 96
TABLE 30 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 97
TABLE 31 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 97
TABLE 32 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION) 97
TABLE 33 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 98
6.2.1 ASSAYS & KITS 98
6.2.1.1 Growing demand for streamlined and user-friendly solutions to drive market 98
TABLE 34 GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY REGION, 2022–2029 (USD MILLION) 99
TABLE 35 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION) 99
TABLE 36 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION) 100
TABLE 37 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION) 100
TABLE 38 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION) 101
TABLE 39 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY REGION, 2022–2029 (USD MILLION) 101
TABLE 40 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION) 101
6.2.2 ENZYMES 102
6.2.2.1 High uptake in molecular techniques to drive market 102
TABLE 41 GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY REGION, 2022–2029 (USD MILLION) 102
TABLE 42 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION) 103
TABLE 43 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION) 103
TABLE 44 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION) 104
TABLE 45 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION) 104
TABLE 46 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY REGION, 2022–2029 (USD MILLION) 104
TABLE 47 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION) 105
6.2.3 DNA CHIPS 105
6.2.3.1 Rising demand across forensic research applications to propel market 105
TABLE 48 GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY REGION, 2022–2029 (USD MILLION) 106
TABLE 49 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION) 106
TABLE 50 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION) 107
TABLE 51 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION) 107
TABLE 52 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION) 108
TABLE 53 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY REGION, 2022–2029 (USD MILLION) 108
TABLE 54 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION) 108
6.2.4 OTHER REAGENTS & CONSUMABLES 109
TABLE 55 GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION) 109
TABLE 56 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 110
TABLE 57 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 110
TABLE 58 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 111
TABLE 59 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 111
TABLE 60 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION) 111
TABLE 61 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 112
6.3 INSTRUMENTS 112
TABLE 62 GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 112
TABLE 63 GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION) 113
TABLE 64 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 65 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 114
TABLE 66 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 114
TABLE 67 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 115
TABLE 68 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION) 115
TABLE 69 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 115
6.3.1 PCR 116
6.3.1.1 Growing focus on development of novel PCR kits to boost demand 116
TABLE 70 GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY REGION, 2022–2029 (USD MILLION) 117
TABLE 71 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 72 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION) 118
TABLE 73 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION) 118
TABLE 74 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION) 119
TABLE 75 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY REGION, 2022–2029 (USD MILLION) 119
TABLE 76 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION) 119
6.3.2 NGS 120
6.3.2.1 Increasing investments in advanced technologies to drive market 120
TABLE 77 GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY REGION, 2022–2029 (USD MILLION) 120
TABLE 78 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION) 121
TABLE 79 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION) 121
TABLE 80 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 81 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 82 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY REGION, 2022–2029 (USD MILLION) 122
TABLE 83 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION) 123
6.3.3 DNA MICROARRAYS 123
6.3.3.1 High-throughput capabilities to propel market 123
TABLE 84 GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY REGION, 2022–2029 (USD MILLION) 124
TABLE 85 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION) 124
TABLE 86 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 87 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 88 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 89 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY REGION 2022–2029 (USD MILLION) 126
TABLE 90 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION) 126
6.3.4 OTHER INSTRUMENTS 127
TABLE 91 GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION) 127
TABLE 92 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 128
TABLE 93 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 128
TABLE 94 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 129
TABLE 95 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 129
TABLE 96 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION) 129
TABLE 97 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 130
6.4 SERVICES 130
TABLE 98 GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 130
TABLE 99 GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY REGION, 2022–2029 (USD MILLION) 131
TABLE 100 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 131
TABLE 101 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 102 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 103 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 133
TABLE 104 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY REGION, 2022–2029 (USD MILLION) 133
TABLE 105 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 133
6.4.1 GENE EXPRESSION ANALYSIS SERVICES 134
TABLE 106 GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 134
6.4.1.1 RNA sequencing services 134
6.4.1.1.1 Rising technological advancements for drug discovery development to propel market 134
TABLE 107 GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY REGION, 2022–2029 (USD MILLION) 135
TABLE 108 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 109 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 136
TABLE 110 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 136
TABLE 111 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 112 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY REGION, 2022–2029 (USD MILLION) 137
TABLE 113 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 137
6.4.1.2 Other services 138
TABLE 114 GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY REGION, 2022–2029 (USD MILLION) 138
TABLE 115 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 139
TABLE 116 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 139
TABLE 117 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 140
TABLE 118 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 140
TABLE 119 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY REGION, 2022–2029 (USD MILLION) 140
TABLE 120 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 141
6.4.2 BIOINFORMATICS SOLUTIONS 141
6.4.2.1 Increasing demand for advanced data analytics to support market growth 141
TABLE 121 GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY REGION, 2022–2029 (USD MILLION) 142
TABLE 122 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 123 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 143
TABLE 124 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 143
TABLE 125 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 126 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY REGION, 2022–2029 (USD MILLION) 144
TABLE 127 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 144
7 GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION 145
7.1 INTRODUCTION 146
TABLE 128 GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 146
7.2 DRUG DISCOVERY & DEVELOPMENT 146
7.2.1 INCREASING INVESTMENTS IN RNA-BASED THERAPEUTICS TO PROPEL MARKET 146
TABLE 129 GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION) 147
TABLE 130 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 147
TABLE 131 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 148
TABLE 132 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 148
TABLE 133 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 134 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION) 149
TABLE 135 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 149
7.3 CLINICAL DIAGNOSTICS 150
7.3.1 RISING UTILIZATION OF MICROARRAYS FOR CANCER DETECTION TO DRIVE MARKET 150
TABLE 136 GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION) 151
TABLE 137 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION) 151
TABLE 138 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION) 152
TABLE 139 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION) 152
TABLE 140 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 141 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION) 153
TABLE 142 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION) 153
7.4 OTHER APPLICATIONS 154
TABLE 143 GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 154
TABLE 144 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 145 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 146 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 156
TABLE 147 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 156
TABLE 148 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 157
TABLE 149 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 157
8 GENE EXPRESSION ANALYSIS MARKET, BY END USER 158
8.1 INTRODUCTION 159
TABLE 150 GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 159
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 159
8.2.1 GROWING FOCUS ON DEVELOPMENT OF TARGETED THERAPIES TO BOOST DEMAND 159
TABLE 151 GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 160
TABLE 152 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 160
TABLE 153 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 154 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 155 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 162
TABLE 156 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 162
TABLE 157 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 162
8.3 ACADEMIC & RESEARCH INSTITUTES 163
8.3.1 INCREASING GOVERNMENT-FUNDED INVESTMENTS TO PROPEL MARKET 163
TABLE 158 GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 164
TABLE 159 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 164
TABLE 160 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 165
TABLE 161 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 165
TABLE 162 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 166
TABLE 163 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 166
TABLE 164 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 166
8.4 OTHER END USERS 167
TABLE 165 GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION) 167
TABLE 166 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 168
TABLE 167 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 168
TABLE 168 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 169
TABLE 169 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 169
TABLE 170 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION) 170
TABLE 171 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 170
9 GENE EXPRESSION ANALYSIS MARKET, BY REGION 171
9.1 INTRODUCTION 172
TABLE 172 GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2022–2029 (USD MILLION) 172
9.2 NORTH AMERICA 173
FIGURE 31 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET SNAPSHOT 173
TABLE 173 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 174
TABLE 174 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 174
TABLE 175 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 174
TABLE 176 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 175
TABLE 177 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 175
TABLE 178 NORTH AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 175
TABLE 179 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 176
TABLE 180 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 176
9.2.1 NORTH AMERICA: RECESSION IMPACT 176
9.2.2 US 177
9.2.2.1 Rising expenditure on NGS-based research to drive market 177
TABLE 181 US: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 177
TABLE 182 US: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 178
TABLE 183 US: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 178
TABLE 184 US: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 178
TABLE 185 US: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 179
TABLE 186 US: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 179
TABLE 187 US: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 179
9.2.3 CANADA 180
9.2.3.1 Increasing incidence of chronic diseases to drive market 180
TABLE 188 CANADA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 180
TABLE 189 CANADA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 181
TABLE 190 CANADA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 181
TABLE 191 CANADA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 181
TABLE 192 CANADA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 182
TABLE 193 CANADA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 182
TABLE 194 CANADA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 182
9.3 EUROPE 183
TABLE 195 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 183
TABLE 196 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 184
TABLE 197 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 184
TABLE 198 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 184
TABLE 199 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 185
TABLE 200 EUROPE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 185
TABLE 201 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 185
TABLE 202 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 186
9.3.1 EUROPE: RECESSION IMPACT 186
9.3.2 GERMANY 186
9.3.2.1 Rising investments in proteomics & genomics research to drive market 186
TABLE 203 GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 187
TABLE 204 GERMANY: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 188
TABLE 205 GERMANY: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 188
TABLE 206 GERMANY: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 188
TABLE 207 GERMANY: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 189
TABLE 208 GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 189
TABLE 209 GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 189
9.3.3 UK 190
9.3.3.1 Favorable government support for genomic research projects to fuel market 190
TABLE 210 UK: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 191
TABLE 211 UK: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 191
TABLE 212 UK: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 191
TABLE 213 UK: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 192
TABLE 214 UK: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 192
TABLE 215 UK: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 192
TABLE 216 UK: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 193
9.3.4 FRANCE 193
9.3.4.1 Increasing R&D in life sciences research to fuel market 193
TABLE 217 FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 194
TABLE 218 FRANCE: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 194
TABLE 219 FRANCE: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 194
TABLE 220 FRANCE: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 195
TABLE 221 FRANCE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 195
TABLE 222 FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 195
TABLE 223 FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 196

9.3.5 ITALY 196
9.3.5.1 Favorable government support for industry-academia collaborations to support market growth 196
TABLE 224 ITALY: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 197
TABLE 225 ITALY: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 197
TABLE 226 ITALY: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 197
TABLE 227 ITALY: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 198
TABLE 228 ITALY: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 198
TABLE 229 ITALY: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 198
TABLE 230 ITALY: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 199
9.3.6 SPAIN 199
9.3.6.1 Growth in biomedical research to boost demand 199
TABLE 231 SPAIN: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 200
TABLE 232 SPAIN: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 200
TABLE 233 SPAIN: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 200
TABLE 234 SPAIN: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 201
TABLE 235 SPAIN: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 201
TABLE 236 SPAIN: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 201
TABLE 237 SPAIN: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 202
9.3.7 REST OF EUROPE 202
TABLE 238 REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 203
TABLE 239 REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 203
TABLE 240 REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 204
TABLE 241 REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 204
TABLE 242 REST OF EUROPE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 204
TABLE 243 REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 205
TABLE 244 REST OF EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 205
9.4 ASIA PACIFIC 205
FIGURE 32 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET SNAPSHOT 206
TABLE 245 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2022–2029 (USD MILLION) 207
TABLE 246 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 207
TABLE 247 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 208
TABLE 248 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 208
TABLE 249 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 208
TABLE 250 ASIA PACIFIC: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 209
TABLE 251 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 209
TABLE 252 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 209
9.4.1 ASIA PACIFIC: RECESSION IMPACT 210
9.4.2 CHINA 210
9.4.2.1 Rising incidence of infectious diseases to boost demand 210
TABLE 253 CHINA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 211
TABLE 254 CHINA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 211
TABLE 255 CHINA GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 211
TABLE 256 CHINA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 212
TABLE 257 CHINA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 212
TABLE 258 CHINA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 212
TABLE 259 CHINA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 213
9.4.3 JAPAN 213
9.4.3.1 Rising technological advancements in sequencing systems to propel market 213
TABLE 260 JAPAN: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 214
TABLE 261 JAPAN: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 214
TABLE 262 JAPAN: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 214
TABLE 263 JAPAN: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 215
TABLE 264 JAPAN: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 215
TABLE 265 JAPAN: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 215
TABLE 266 JAPAN: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 216
9.4.4 INDIA 216
9.4.4.1 Robust growth in biopharmaceutical industry to drive market 216
TABLE 267 INDIA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 217
TABLE 268 INDIA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 217
TABLE 269 INDIA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 218
TABLE 270 INDIA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 218
TABLE 271 INDIA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 218
TABLE 272 INDIA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 219
TABLE 273 INDIA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 219
9.4.5 AUSTRALIA 219
9.4.5.1 Increasing focus on R&D expenditure to drive market 219
TABLE 274 AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 220
TABLE 275 AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 220
TABLE 276 AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 221
TABLE 277 AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 221
TABLE 278 AUSTRALIA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 221
TABLE 279 AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 222
TABLE 280 AUSTRALIA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 222
9.4.6 SOUTH KOREA 222
9.4.6.1 Rising prevalence of chronic diseases to boost demand 222
TABLE 281 SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 223
TABLE 282 SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 223
TABLE 283 SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 224
TABLE 284 SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 224
TABLE 285 SOUTH KOREA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 224
TABLE 286 SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 225
TABLE 287 SOUTH KOREA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 225
9.4.7 REST OF ASIA PACIFIC 226
TABLE 288 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 226
TABLE 289 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 227
TABLE 290 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 227
TABLE 291 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 227
TABLE 292 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 228
TABLE 293 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 228
TABLE 294 REST OF ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 228
9.5 LATIN AMERICA 229
TABLE 295 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2022–2029 (USD MILLION) 229
TABLE 296 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 229
TABLE 297 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 230
TABLE 298 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 230
TABLE 299 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 230
TABLE 300 LATIN AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 231
TABLE 301 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 231
TABLE 302 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 231
9.5.1 LATIN AMERICA: RECESSION IMPACT 232
9.5.2 BRAZIL 232
9.5.2.1 Growth in biopharmaceutical industry to support market 232
TABLE 303 BRAZIL: GENE EXPRESSION ANALYSIS MARKET BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 233
TABLE 304 BRAZIL: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 233
TABLE 305 BRAZIL: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 233
TABLE 306 BRAZIL: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 234
TABLE 307 BRAZIL: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 234
TABLE 308 BRAZIL: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 234
TABLE 309 BRAZIL: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 235
9.5.3 MEXICO 235
9.5.3.1 Increasing incidence of diabetes and growing geriatric population to propel market 235
TABLE 310 MEXICO: GENE EXPRESSION ANALYSIS MARKET BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 236
TABLE 311 MEXICO: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 236
TABLE 312 MEXICO: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 236
TABLE 313 MEXICO: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 237
TABLE 314 MEXICO: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 237
TABLE 315 MEXICO: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 237
TABLE 316 MEXICO: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 238
9.5.4 REST OF LATIN AMERICA 238
TABLE 317 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 238
TABLE 318 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 239
TABLE 319 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 239
TABLE 320 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 239
TABLE 321 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 240
TABLE 322 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 240
TABLE 323 REST OF LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 240
9.6 MIDDLE EAST 241
TABLE 324 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2022–2029 (USD MILLION) 241
TABLE 325 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 241
TABLE 326 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 242
TABLE 327 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 242
TABLE 328 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 242
TABLE 329 MIDDLE EAST: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 243
TABLE 330 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 243
TABLE 331 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 243
9.6.1 MIDDLE EAST: RECESSION IMPACT 244
9.6.2 GCC COUNTRIES 244
TABLE 332 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 244
TABLE 333 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 244
TABLE 334 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 245
TABLE 335 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 245
TABLE 336 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 245
TABLE 337 GCC COUNTRIES: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 246
TABLE 338 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 246
TABLE 339 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 246
9.6.2.1 Saudi Arabia 247
9.6.2.1.1 Increasing investments in pharmaceutical R&D to support market growth 247
TABLE 340 SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 247
TABLE 341 SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 248
TABLE 342 SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 248
TABLE 343 SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 248
TABLE 344 SAUDI ARABIA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 249
TABLE 345 SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 249
TABLE 346 SAUDI ARABIA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 249
9.6.2.2 United Arab Emirates 250
9.6.2.2.1 Growing R&D expenditure and advanced healthcare infrastructure to fuel market 250
TABLE 347 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 250
TABLE 348 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 251
TABLE 349 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 251
TABLE 350 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 251
TABLE 351 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 252
TABLE 352 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 252
TABLE 353 UNITED ARAB EMIRATES: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 252
9.6.2.3 Other GCC Countries 253
TABLE 354 OTHER GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 253
TABLE 355 OTHER GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 254
TABLE 356 OTHER GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 254
TABLE 357 OTHER GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 254
TABLE 358 OTHER GCC COUNTRIES: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 255
TABLE 359 OTHER GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 255
TABLE 360 OTHER GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 255
9.6.3 REST OF MIDDLE EAST 256
TABLE 361 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 256
TABLE 362 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 257
TABLE 363 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 257
TABLE 364 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 257
TABLE 365 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 258
TABLE 366 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 258
TABLE 367 REST OF MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 258
9.7 AFRICA 259
9.7.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH 259
TABLE 368 AFRICA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 259
TABLE 369 AFRICA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 260
TABLE 370 AFRICA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 260
TABLE 371 AFRICA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 260
TABLE 372 AFRICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 261
TABLE 373 AFRICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 261
TABLE 374 AFRICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 261
9.7.2 AFRICA: RECESSION IMPACT 262
10 COMPETITIVE LANDSCAPE 263
10.1 INTRODUCTION 263
10.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 263
FIGURE 33 GENE EXPRESSION ANALYSIS: STRATEGIES DEPLOYED BY GENE EXPRESSION ANALYSIS PLAYERS 263
10.3 REVENUE SHARE ANALYSIS 264
FIGURE 34 REVENUE SHARE ANALYSIS OF KEY PLAYERS (2021–2023) 264
10.4 MARKET SHARE ANALYSIS 264
FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023) 265
TABLE 375 GENE EXPRESSION ANALYSIS MARKET: INTENSITY OF COMPETITIVE RIVALRY 265
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS 266
10.5.1 STARS 266
10.5.2 EMERGING LEADERS 266
10.5.3 PERVASIVE PLAYERS 267
10.5.4 PARTICIPANTS 267
FIGURE 36 GENE EXPRESSION ANALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 267
10.5.5 COMPANY FOOTPRINT ANALYSIS 268
FIGURE 37 GENE EXPRESSION ANALYSIS MARKET: COMPANY FOOTPRINT (2023) 268
TABLE 376 GENE EXPRESSION ANALYSIS MARKET: TYPE FOOTPRINT 269
TABLE 377 GENE EXPRESSION ANALYSIS MARKET: REGIONAL FOOTPRINT 269
10.6 COMPANY EVALUATION MATRIX: START-UP/SME PLAYERS 270
10.6.1 PROGRESSIVE COMPANIES 270
10.6.2 STARTING BLOCKS 270
10.6.3 RESPONSIVE COMPANIES 270
10.6.4 DYNAMIC COMPANIES 270
FIGURE 38 GENE EXPRESSION ANALYSIS MARKET: START-UP/SME EVALUATION MATRIX (2023) 271
10.7 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 272
TABLE 378 GENE EXPRESSION ANALYSIS MARKET: DETAILED LIST OF KEY START-UPS/SMES 272
TABLE 379 GENE EXPRESSION ANALYSIS MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 273
10.8 VALUATION AND FINANCIAL METRICS OF GENE EXPRESSION ANALYSIS VENDORS 274
FIGURE 39 EV/EBITDA OF KEY VENDORS 274
FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 274
10.9 BRAND/PRODUCT COMPARATIVE ANALYSIS 275
10.9.1 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL 275
FIGURE 41 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY MODEL 275
10.10 COMPETITIVE SCENARIO 276
10.10.1 PRODUCT LAUNCHES 276
TABLE 380 GENE EXPRESSION ANALYSIS MARKET: PRODUCT LAUNCHES (JANUARY 2021–JANUARY 2024) 277
10.10.2 DEALS 278
TABLE 381 GENE EXPRESSION ANALYSIS MARKET: DEALS (JANUARY 2021–JANUARY 2024) 278
10.10.3 EXPANSIONS 279
TABLE 382 GENE EXPRESSION ANALYSIS MARKET: EXPANSIONS (JANUARY 2021–JANUARY 2024) 279
10.10.4 OTHER DEVELOPMENTS 280
TABLE 383 GENE EXPRESSION ANALYSIS: OTHER DEALS/DEVELOPMENTS (JANUARY 2021–JANUARY 2024) 280
11 COMPANY PROFILES 281
(Business overview, Products/Services offered, Recent developments & MnM View)*
11.1 KEY PLAYERS 281
11.1.1 THERMO FISHER SCIENTIFIC INC. 281
TABLE 384 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 281
FIGURE 42 THERMOFISHER SCIENTIFIC INC: COMPANY SNAPSHOT (2022) 282
TABLE 385 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 282
TABLE 386 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES 288
TABLE 387 THERMO FISHER SCIENTIFIC INC.: DEALS 289
11.1.2 BIO-RAD LABORATORIES, INC. 290
TABLE 388 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 290
FIGURE 43 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022) 291
TABLE 389 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED 291
TABLE 390 BIO-RAD LABORATORIES, INC.: DEALS 295
11.1.3 ILLUMINA, INC. 297
TABLE 391 ILLUMINA, INC.: COMPANY OVERVIEW 297
FIGURE 44 ILLUMINA, INC.: COMPANY SNAPSHOT (2022) 298
TABLE 392 ILLUMINA, INC.: PRODUCTS/SERVICES OFFERED 298
TABLE 393 ILLUMINA, INC.: OTHER DEVELOPMENTS 301
11.1.4 QIAGEN 302
TABLE 394 QIAGEN: COMPANY OVERVIEW 302
FIGURE 45 QIAGEN: COMPANY SNAPSHOT (2022) 303
TABLE 395 QIAGEN: PRODUCTS/SERVICES OFFERED 303
TABLE 396 QIAGEN: PRODUCT LAUNCHES 307
TABLE 397 QIAGEN: DEALS 307
11.1.5 F. HOFFMANN-LA ROCHE LTD. 309
TABLE 398 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 309
FIGURE 46 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022) 310
TABLE 399 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED 310
TABLE 400 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES 311
11.1.6 REVVITY 312
TABLE 401 REVVITY: COMPANY OVERVIEW 312
FIGURE 47 REVVITY: COMPANY SNAPSHOT (2022) 313
TABLE 402 REVVITY: PRODUCTS/SERVICES OFFERED 313
TABLE 403 REVVITY: PRODUCT LAUNCHES 315
TABLE 404 REVVITY: DEALS 315
TABLE 405 REVVITY: OTHER DEVELOPMENTS 315
11.1.7 PACBIO 316
TABLE 406 PACBIO: COMPANY OVERVIEW 316
FIGURE 48 PACBIO: COMPANY SNAPSHOT (2022) 317
TABLE 407 PACBIO: PRODUCTS/SERVICES OFFERED 317
TABLE 408 PACBIO: PRODUCT LAUNCHES 318
TABLE 409 PACBIO: DEALS 319
TABLE 410 PACBIO: OTHER DEVELOPMENTS 319
11.1.8 AGILENT TECHNOLOGIES, INC. 320
TABLE 411 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 320
FIGURE 49 AGILENT TECHNOLOGIES, INC: COMPANY SNAPSHOT (2023) 321
TABLE 412 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED 321
TABLE 413 AGILENT TECHNOLOGIES, INC.: DEALS 324
TABLE 414 AGILENT TECHNOLOGIES, INC.: OTHER DEVELOPMENTS 325
11.1.9 SYSMEX CORPORATION 326
TABLE 415 SYSMEX CORPORATION: COMPANY OVERVIEW 326
FIGURE 50 SYSMEX CORPORATION: COMPANY SNAPSHOT (2023) 326
TABLE 416 SYSMEX CORPORATION: PRODUCTS/SERVICES OFFERED 327
TABLE 417 SYSMEX CORPORATION: DEALS 328
TABLE 418 SYSMEX CORPORATION: OTHER DEVELOPMENTS 328
11.1.10 BGI 329
TABLE 419 BGI: COMPANY OVERVIEW 329
TABLE 420 BGI: PRODUCTS/SERVICES OFFERED 330
TABLE 421 BGI: DEALS 330
11.1.11 EUROFINS SCIENTIFIC SE 331
TABLE 422 EUROFINS SCIENTIFIC SE: COMPANY OVERVIEW 331
FIGURE 51 EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2022) 331
TABLE 423 EUROFINS SCIENTIFIC SE: PRODUCTS/SERVICES OFFERED 332
TABLE 424 EUROFINS SCIENTIFIC SE: OTHER DEVELOPMENTS 332
11.1.12 STANDARD BIOTOOLS 333
TABLE 425 STANDARD BIOTOOLS: COMPANY OVERVIEW 333
FIGURE 52 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2022) 334
TABLE 426 STANDARD BIOTOOLS: PRODUCTS/SERVICES OFFERED 334
TABLE 427 STANDARD BIOTOOLS: PRODUCT LAUNCHES 335
11.1.13 OXFORD NANOPORE TECHNOLOGIES PLC 336
TABLE 428 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY OVERVIEW 336
TABLE 429 OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCTS/SERVICES OFFERED 336
TABLE 430 OXFORD NANOPORE TECHNOLOGIES PLC: DEALS 337
11.1.14 GENSCRIPT 338
TABLE 431 GENSCRIPT: COMPANY OVERVIEW 338
FIGURE 53 GENSCRIPT: COMPANY SNAPSHOT 339
TABLE 432 GENSCRIPT: PRODUCTS/SERVICES OFFERED 339
TABLE 433 GENSCRIPT: OTHER DEVELOPMENTS 341
11.1.15 TAKARA BIO INC. 342
TABLE 434 TAKARA BIO INC.: COMPANY OVERVIEW 342
FIGURE 54 TAKARA BIO INC.: COMPANY SNAPSHOT (2023) 343
TABLE 435 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED 343
TABLE 436 TAKARA BIO INC.: PRODUCT LAUNCHES 348
*Details on Business overview, Products/Services offered, Recent developments & MnM View might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS 349
11.2.1 10X GENOMICS INC. 349
11.2.2 ZYMO RESEARCH CORPORATION 350
11.2.3 TWIST BIOSCIENCE 351
11.2.4 PROMEGA CORPORATION 352
11.2.5 LGC LIMITED 354
11.2.6 CD GENOMICS 355
11.2.7 NANOSTRING TECHNOLOGIES, INC. 356
11.2.8 BIOSPYDER, INC 357
11.2.9 INTEGRATED DNA TECHNOLOGIES, INC. 358
11.2.10 NEW ENGLAND BIOLABS, INC. 359
12 APPENDIX 362
12.1 DISCUSSION GUIDE 362
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 366
12.3 CUSTOMIZATION OPTIONS 368
12.4 RELATED REPORTS 368
12.5 AUTHOR DETAILS 369

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の遺伝子発現解析市場（～2029年）：製品別（試薬、酵素、キット、DNAチップ、PCR、NGS、DNAマイクロアレイ）、サービス別（RNAシーケンス、バイオインフォマティクス）、用途別（創薬・開発、臨床診断）、エンドユーザー別(Gene Expression Analysis Market by Product (Reagents, Enzymes, kits, DNA Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Bioinformatics), Application (Drug discovery & development, clinical diagnostics), End User - Global Forecast to 2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp